Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress

1. 22.

   STING-Dependent Type I IFN Production Inhibits Cell-Mediated Immunity to Listeria monocytogenes · 2014

2. 57.

   Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy · 2014

3. 98.

   NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives · 2018

101 more references, whose wording the paper’s licence keeps private.

• A programmable encapsulation system improves delivery of therapeutic bacteria in mice · 2022

• Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity · 2020

• The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease · 2020

• Bacteria-cancer interactions: bacteria-based cancer therapy · 2019

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.